For the purposes of this document, "potentially infectious waste" shall also mean biohazadous, biomedical, red bag, or regulated medical waste, as those terms are defined under federal, state or local laws, rules, regulations and guidelines. The following waste streams are generally considered within the definition of "potentially infectious waste": Blood: Includes waste blood, serum plasma, and the products and components of blood. Sharps: Includes hypodermic needles, syringes, scalpels, pipettes, broken glass, and other medical instruments that have come into contact with infectious agents during patient care or laboratory research. Wastes From Surgery or Autopsy: Includes soiled dressings, sponges, drapes, lavage tubes, drainage sets, under pads, and surgical gloves. Dialysis Wastes, (Including Contaminated Disposable Equipment and Supplies): Includes tubing, filters, disposable sheets, towels, gloves, aprons, and lab coats. Other Wastes: Various other biological waste and discarded material contaminated with or exposed to blood, excretion, or secretions from human beings or animals. Pathological Waste: Pathological wastes, considered infectious because of the possibility of infection in the patient or corpse, include tissues, organs, body parts, blood and body fluids removed during surgery, autopsy, and biopsy. Pathological Wastes includes contaminated animal carcasses, body parts, and bedding of animals that were intentionally exposed to pathogens. Pharmaceutical Waste: Pharmaceutical waste that meets the RCRA (or any applicable more stringent state regulations) criteria and definition of "Non-Hazardous Waste" may be accepted following approval by Tridecon. A list of all drugs, with national drug code (NDC) number, manufacturer name, and trade or brand name for each product is necessary for waste characterization and approval. No hazardous pharmaceutical waste will be accepted. |